Periprosthetic Joint Infection — One-Stage (Single-Stage) Revision

ArthroplastyAdvancedCore Procedure

Periprosthetic Joint Infection — One-Stage (Single-Stage) Revision

Operative technique guide for single-stage exchange revision arthroplasty in periprosthetic joint infection — patient selection criteria, radical debridement, re-draping protocol, antibiotic-loaded cement reimplantation, evidence base versus two-stage exchange, and rehabilitation

High-yield overview

Single-stage exchange revision for chronic PJI in selected patients | advanced

Surgical Imaging

Critical Danger Structures and Exam Traps
Sinus Tract — Absolute Contraindication

The trap: Attempting one-stage revision when a sinus tract is present — the tract indicates chronic fistulous communication with skin flora and guarantees polymicrobial or resistant contamination.

The fix: Any sinus tract mandates two-stage exchange or, at minimum, excision of the tract with temporary spacer before considering reimplantation. One-stage protocols explicitly exclude sinus tracts.

Unknown or Resistant Organism

The trap: Proceeding to one-stage exchange without a preoperative culture identifying a susceptible organism — you cannot select appropriate local and systemic antibiotics.

The fix: Preoperative aspiration or biopsy with organism identification and susceptibility testing is mandatory. Resistant organisms (MRSA, VRE, fungi, MDR Gram-negatives) are managed with two-stage protocols or suppressive therapy.

Immunocompromised Host

The trap: Offering one-stage revision to patients on chemotherapy, high-dose steroids, biologics, or with uncontrolled diabetes, HIV, or dialysis dependence — host immunity is insufficient to clear residual biofilm.

The fix: These patients require two-stage exchange with prolonged antibiotic holiday and optimisation; one-stage success rates drop dramatically in immunocompromised hosts.

Inadequate Bone Stock or Soft-Tissue Envelope

The trap: Assuming immediate reimplantation is feasible when major bone loss or poor soft-tissue coverage exists — the new implant will have no stable fixation or coverage.

The fix: Assess bone defects with CT; if Paprosky type III or greater femoral/acetabular loss or significant soft-tissue deficiency, convert to two-stage with spacer and plan for augments or flaps at reimplantation.

Failure to Re-Drape and Change Instruments

The trap: Completing debridement and immediately reimplanting with the same drapes and instruments — this recontaminates the new prosthesis with residual bacteria from the infected field.

The fix: After explantation and thorough debridement, remove all drapes, re-scrub, re-gown, apply completely new drapes, and open an entirely new sterile instrument set before reimplantation. This step is the hallmark of a true one-stage protocol.

DAIR versus One-Stage Confusion

The trap: Confusing one-stage exchange with DAIR — DAIR retains the original implants and is indicated only for acute postoperative or haematogenous infections within 3-4 weeks of symptoms.

The fix: One-stage exchange is for chronic PJI (greater than 4 weeks of symptoms) with known organism; it always involves complete explantation and reimplantation. DAIR leaves the implants in situ.

Mnemonic

S.E.L.E.C.T.SELECT — One-Stage Patient Selection Criteria

Mnemonic

S.T.E.P.S.STEPS — One-Stage Operative Sequence

Mnemonic

O.U.T.C.O.M.E.OUTCOME — Evidence and Limitations

Surgical Indications for One-Stage Revision

Absolute Indications (Endo-Klinik Criteria)

  • Chronic periprosthetic joint infection (symptoms greater than 4 weeks) with a single, known, susceptible organism identified on preoperative aspiration or biopsy
  • Immunocompetent host with well-controlled comorbidities and no active systemic infection
  • Healthy soft-tissue envelope without sinus tract, abscess, or significant scarring
  • Adequate bone stock permitting immediate stable reimplantation without major structural augments
  • Organism susceptible to biofilm-active antibiotics that can be delivered both locally in cement and systemically

Relative Indications

  • Patient preference for single anaesthetic exposure after informed discussion of success rates versus two-stage
  • Low-virulence organisms (coagulase-negative staphylococci, Cutibacterium, streptococci) with proven susceptibility
  • Well-fixed implants with minimal bone loss on preoperative imaging

Contraindications

Absolute:

  • Presence of sinus tract or fistulous communication
  • Unknown organism or culture-negative PJI
  • Resistant or difficult-to-treat organisms (MRSA, VRE, fungi, MDR Gram-negatives, rifampicin-resistant staphylococci)
  • Immunocompromised state (chemotherapy, biologics, uncontrolled diabetes with HbA1c greater than 8 percent, dialysis, HIV with low CD4)
  • Significant soft-tissue deficiency requiring flap coverage
  • Major bone defects (Paprosky III or greater) precluding immediate stable fixation

Relative:

  • Acute postoperative or haematogenous PJI (these are DAIR indications)
  • Previous failed one-stage revision
  • Patient unable to comply with prolonged postoperative antibiotic course or follow-up

Evidence Comparing One-Stage versus Two-Stage Exchange

One-stage exchange has been performed at the Endo-Klinik since the 1980s with published success rates supporting its use in selected patients. Modern series report reinfection rates of 5-15 percent at 5-10 years when strict selection criteria are applied, comparable to two-stage exchange in appropriately chosen cohorts.

Advantages of one-stage revision include single anaesthetic exposure, shorter total hospital stay, lower cumulative cost, faster return to function, and avoidance of spacer-related complications (spacer dislocation, fracture, or prolonged immobilisation).

Limitations include the requirement for known susceptible organism preoperatively, the technical demand of radical debridement in a single sitting, and the inability to confirm clearance of infection before reimplantation.

One-Stage versus Two-Stage Exchange — Decision Framework


Key Evidence

Evidence

One-Stage Revision for Infected Total Hip Arthroplasty

Level III
Zahar A, Gehrke TAOrthop Clin North Am
Source: Orthop Clin North Am. 2016 Jan;47(1):11-8
Evidence

One- and two-stage surgical revision of peri-prosthetic joint infection of the hip: a pooled individual participant data analysis of 44 cohort studies

Level II
Kunutsor SK, Whitehouse MR, Blom AW, et al.Eur J Epidemiol
Source: Eur J Epidemiol. 2018 Oct;33(10):933-946
Evidence

Re-Infection Outcomes Following One- And Two-Stage Surgical Revision of Infected Knee Prosthesis: A Systematic Review and Meta-Analysis

Level II
Kunutsor SK, Whitehouse MR, Blom AW, et al.PLoS One
Source: PLoS One. 2016;11(3):e0151537
Evidence

One- and two-stage surgical revision of infected shoulder prostheses following arthroplasty surgery: A systematic review and meta-analysis

Level II
Kunutsor SK, Wylde V, Beswick AD, et al.Sci Rep
Source: Sci Rep. 2019 Jan 18;9(1):232

Clinical Decision Scenarios

Practise clinical reasoning and management decisions out loud

Viva scenarioAdvanced
Clinical prompt

A 68-year-old man with a well-fixed cemented total hip arthroplasty presents with insidious groin pain 4 years after index surgery. CRP is 35 mg/L, ESR 45 mm/hr. Aspiration grows coagulase-negative Staphylococcus sensitive to vancomycin and rifampicin. There is no sinus tract, he is immunocompetent, and CT shows only minor osteolysis around the cup. Is he a candidate for one-stage revision, and what are the key technical steps you would emphasise?

Practical approach
Yes, this patient meets all Endo-Klinik selection criteria for one-stage revision: known susceptible low-virulence organism, no sinus tract, healthy host, adequate bone stock, and healthy soft tissues. **Key technical steps I would emphasise**: 1. Posterior approach with complete exposure and tagging of external rotators. 2. Minimum five deep tissue samples obtained before any antibiotic administration. 3. Complete explantation of both components and thorough removal of all cement and membrane using curettes, high-speed burr, and pulse lavage (greater than 9 litres). 4. The critical re-draping step: complete removal of all drapes, re-scrub, new sterile field, and entirely new instrument set before reimplantation. 5. Reimplantation with vancomycin- and gentamicin-loaded cement; verify cup and stem stability, leg length, and stability. 6. Postoperative 4-6 weeks of targeted intravenous vancomycin followed by oral rifampicin combination therapy under infectious-disease guidance. I would counsel the patient that success rates in selected one-stage cases are 85-95 percent at 5 years, comparable to two-stage, with the advantage of single surgery and faster recovery.
Viva scenarioAdvanced
Clinical prompt

You are planning a one-stage revision for an infected total knee arthroplasty. The patient has a known methicillin-sensitive Staphylococcus aureus (MSSA) on preoperative aspiration. During the case, after radical debridement and explantation, you notice that the medial collateral ligament has been compromised by the infectious process. How do you proceed?

Practical approach
The discovery of an incompetent medial collateral ligament changes the implant choice but does not necessarily preclude one-stage revision if all other selection criteria remain satisfied. **Intraoperative decision-making**: - Confirm that the organism (MSSA) remains susceptible and that the soft-tissue envelope is still adequate for coverage. - Because the MCL is incompetent, a constrained condylar knee (CCK) or rotating-hinge implant will be required for stability rather than a standard primary or posterior-stabilised component. - Proceed with the re-draping protocol exactly as planned: complete removal of drapes, re-scrub, new sterile field, and new instrument tray. - Select a constrained implant that can be cemented with antibiotic-loaded cement (vancomycin plus gentamicin for MSSA). - Verify that the bone cuts allow stable fixation of the constrained components without excessive constraint-related stress. - Close over drains and begin targeted intravenous antibiotics immediately postoperatively. If the soft-tissue deficiency had been more severe (for example requiring a flap), I would have aborted one-stage and inserted an antibiotic spacer for two-stage reconstruction.
Viva scenarioAdvanced
Clinical prompt

A 72-year-old woman with an infected total hip arthroplasty has a sinus tract communicating with the joint. Aspiration grows a fully susceptible coagulase-negative Staphylococcus. She is otherwise fit and the bone stock is good. Why is one-stage revision contraindicated, and what is the correct management?

Practical approach
The presence of a sinus tract is an absolute contraindication to one-stage revision regardless of organism susceptibility or host status. **Rationale**: A sinus tract represents a chronic fistulous communication between the joint and skin flora. Even after radical debridement, the tract and surrounding scarred tissue harbour polymicrobial contamination that cannot be reliably eradicated in a single procedure. Attempting one-stage in this setting carries an unacceptably high reinfection rate. **Correct management**: - Two-stage exchange is the standard of care. - First stage: complete explantation, radical debridement, excision of the entire sinus tract, and insertion of an antibiotic-loaded cement spacer (static or articulating). - Six-week course of targeted intravenous antibiotics with infectious-disease oversight; confirm clearance with repeat aspiration before second stage. - Second stage: reimplantation only after clinical, serological, and aspiration evidence of infection eradication (typically 6-12 weeks after first stage). - If the sinus tract is small and the organism low-virulence, some centres perform one-stage with simultaneous tract excision, but this is outside standard Endo-Klinik one-stage criteria and carries higher risk.
Exam day cheat sheet
Periprosthetic Joint Infection — One-Stage Revision — Exam Day Summary
Editorially reviewed — transparent references and correction processPublished by OrthoVellum Medical Education TeamEditorial boardMethodologyReview policy
Educational disclosure

Educational content is reviewed for source visibility, editorial coherence, and correction readiness.

No individual clinician credential is claimed unless a named person is shown.

Verify before clinical use; this is not medical advice or a substitute for local guidance.